Technology - SIME Clinical AI

APRIL 2025: NEW ADULT ICU POC DIAGNOSTIC TEST MEASURES CRITICAL LUNG MATURITY BIOMARKER IN MINUTES

READ NOW

DISEASE PREDICTION POWERED BY
PROPRIETARY AI

SIME’s advanced AI is founded on decades of award winning mathematical research. Research dedicated to deciphering the world’s most complex, variable and valuable database – the human body.

Common framework for linear regression Latent Structure Linear Regression H-methods in applied sciences Applications of the H-Principle of Mathematical Modelling

long-established
CLINICAL EXPERTISE

With over 40 published papers, and pioneering research that still directs the current global standard of neonatal respiratory care, our team are at the frontier of medical innovation.

Early Surfactant Guided by Lamellar Body Counts Nasal CPAP and Early Surfactant Therapy Prophylactic or Early Selective Surfactant

CLINICALLY PROVEN
PREDICTIVE DIAGNOSTICS

Our platform unlocks the data stored in a patient’s biological fingerprint – generating proprietary data so unique and rich, it can only be deciphered by AI.

This data enables rapid disease prediction, when it matters most. Our diagnostic platform has been scientifically proven in multiple peer reviewed clinical trials.

Predicting RDS at birth using a fast test based on spectroscopy Rapid determination of lung maturity by mid-infrared spectroscopy Simultaneous determination of multiple markers without reagents